ZBTB16 and cancer: K-M survival analysis demonstrated that the expression of ZBTB16 was related closely to overall survival (OS) of the HCC patients, with high expression indicating better survival (Fig. 4B), especially in patients with stages III- IV cancers (Fig. 4C).